|
||||
|
|
||||
|
|
Study: Malignant Pheo, Paraganglioma, Metastatic Carcinoid Molecular Insight Pharmaceuticals, Inc. conducted and completed a clinical trial to benefit patients with certain types of pheochromocytoma, paraganglioma or metastatic carcinoid tumors.
2009 Pheochromocytoma and Paraganglioma Conference
The Pheo-Para Alliance has announced the 2009 conference to be held in Parsippany, NJ. September 30 through October 2.
Karel Pacak will be the key note speaker on Pheochromocytoma: An overview of Research Achievements.
For details of this event and information, please refer to the link directly below.
2009 Pheochromocytoma and Paraganglioma Conference
Pheochromocytoma Support Board
|
|
||
